Literature DB >> 18824772

Survival after resection of primary cardiac tumors: a 48-year experience.

Andrew W Elbardissi1, Joseph A Dearani, Richard C Daly, Charles J Mullany, Thomas A Orszulak, Francisco J Puga, Hartzell V Schaff.   

Abstract

BACKGROUND: Primary cardiac tumors are rare but have the potential to cause significant morbidity if not treated in an appropriate and timely manner. To date, however, there have been no studies examining survival characteristics of patients who undergo surgical resection. METHODS AND
RESULTS: From 1957 to 2006, 323 consecutive patients underwent surgical resection of primary cardiac tumors; 163 (50%) with myxomas, 83 (26%) with papillary fibroelastomas, 18 (6%) with fibromas, 12 (4%) with lipomas, 28 (9%) with other benign primary cardiac tumors, and 19 (6%) with primary malignant tumors. Operative (30 day) mortality was 2% (n=6). Univariate analysis indicated that patients who underwent resection of fibromas and myxomas had superior survival characteristics in comparison to the remainder of tumor variants; these results were consistent after adjusting for age at surgery, year of surgery, and cardiovascular risk factors. Based on actuarial characteristics of the 2002 U.S. population, patients who underwent myxoma resection had survival characteristics that were not significantly different from that of an age and gender matched population (SMR 1.11, P=0.57) whereas those who underwent resection of fibromas (SMR 11.17, P=0.002), papillary fibroelastomas (SMR 3.17, P=0.0003), lipomas (SMR 5.0, P=0.0003), other benign tumors (SMR 4.63, P=0.003), and malignant tumors (SMR 101, P<0.0001) had significantly poorer survival characteristics. Furthermore, malignant tumors in younger patients were highly fatal (HR 0.899, P<0.0001). Although the most significant predictor of mortality was tumor histology, survival was also influenced the by the duration of CPB and NYHA III/IV; the impact of these risk factors varied with time. The cumulative incidence of myxoma recurrence was 13% and occurred in a younger population (42 versus 57 years, P=0.003) with the risk of recurrence decreased after 4 years.
CONCLUSIONS: Surgical resection of primary cardiac tumors is associated with excellent long-term survival; patients with cardiac myxomas have survival characteristics that are not significantly different from that of a general population. Predictors of mortality are primarily related to tumor histology but also include clinical characteristics such as symptomatology and duration of CPB.

Entities:  

Mesh:

Year:  2008        PMID: 18824772     DOI: 10.1161/CIRCULATIONAHA.107.783126

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  73 in total

Review 1.  Calcified amorphous tumour of the heart: presentation of a rare case operated using minimal access cardiac surgery.

Authors:  Lisa Greaney; Sanjay Chaubey; Sabine Pomplun; Emma St Joseph; Mark Monaghan; Olaf Wendler
Journal:  BMJ Case Rep       Date:  2011-06-03

2.  Lipoma in the right atrium.

Authors:  I D Kilic; I Alur; Y I Alihanoglu; B S Yildiz; F Bir; A V Ozcan
Journal:  Herz       Date:  2013-10-25       Impact factor: 1.443

Review 3.  The Assessment of Cardiac Masses by Cardiac CT and CMR Including Pre-op 3D Reconstruction and Planning.

Authors:  Stephen Liddy; Colin McQuade; Kevin P Walsh; Bryan Loo; Orla Buckley
Journal:  Curr Cardiol Rep       Date:  2019-07-31       Impact factor: 2.931

4.  Surgical treatment of cardiac tumors: a 5-year experience from a single cardiac center.

Authors:  Liang Yin; Dengke He; Hua Shen; Xinyu Ling; Wei Li; Qian Xue; Zhinong Wang
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

5.  A ventricular thrombus mimicking a tumour.

Authors:  Julio Flávio Meirelles Marchini; Alfredo Jose Rodrigues; Andre Schmidt
Journal:  BMJ Case Rep       Date:  2009-09-01

6.  Electroanatomical mapping-assisted surgical treatment of incessant ventricular tachycardia associated with an intramyocardial giant lipoma.

Authors:  Shun-Ichiro Sakamoto; Takashi Nitta; Hiroshige Murata; Takahide Yoshio; Masami Ochi; Kazuo Shimizu
Journal:  J Interv Card Electrophysiol       Date:  2011-06-11       Impact factor: 1.900

7.  Surgical experience with cardiac papillary fibroelastoma over a 15-year period.

Authors:  Melissa M Anastacio; Marc R Moon; Ralph J Damiano; Michael K Pasque; Hersh S Maniar; Jennifer S Lawton
Journal:  Ann Thorac Surg       Date:  2012-05-23       Impact factor: 4.330

8.  Fibroelastoma Recurrence in Left Ventricle: Rarity of Primary Cardiac Tumor.

Authors:  Inna Kammerer; Reinhard Besser; Mohammed Al-Azani; Christian Frank; Manfred H Bohrer; Falk-Udo Sack
Journal:  Surg J (N Y)       Date:  2015-11-05

9.  Unusual appearance of a cardiac mass.

Authors:  Wern Yew Ding; Mohammed Meah; Richard Hawkins; Paul Mann
Journal:  Intern Emerg Med       Date:  2017-11-17       Impact factor: 3.397

10.  Incremental value of cardiac magnetic resonance for the evaluation of cardiac tumors in adults: experience of a high volume tertiary cardiology centre.

Authors:  Sorin Giusca; Derliz Mereles; Andreas Ochs; Sebastian Buss; Florian André; Sebastian Seitz; Johannes Riffel; Philipp Fortner; Mindaugas Andrulis; Stefan Schönland; Hugo A Katus; Grigorios Korosoglou
Journal:  Int J Cardiovasc Imaging       Date:  2017-01-30       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.